Marathon Capital Management Dyadic International Inc Transaction History
Marathon Capital Management
- $414 Million
- Q3 2025
A detailed history of Marathon Capital Management transactions in Dyadic International Inc stock. As of the latest transaction made, Marathon Capital Management holds 35,000 shares of DYAI stock, worth $32,200. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,000Holding current value
$32,200% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding DYAI
# of Institutions
41Shares Held
6.18MCall Options Held
0Put Options Held
0-
Apis Capital Advisors, LLC New York, NY1.54MShares$1.42 Million0.57% of portfolio
-
Chapin Davis, Inc. Baltimore, MD932KShares$857,4430.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA915KShares$841,7630.0% of portfolio
-
Perkins Capital Management Inc348KShares$320,2060.41% of portfolio
-
Truist Financial Corp326KShares$300,1040.0% of portfolio
About DYADIC INTERNATIONAL INC
- Ticker DYAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,423,100
- Market Cap $26.1M
- Description
- Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...